EARNEST Partners’s CVS Health CVS Stock Holding History

EARNEST Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-597	Closed	-$41.7K	–	486
2023 Q3	$41.7K	Hold	597	–	–	﹤0.01%	383
2023 Q2	$41.3K	Hold	597	–	–	﹤0.01%	367
2023 Q1	$44.4K	Hold	597	–	–	﹤0.01%	356
2022 Q4	$55.6K	Hold	597	–	–	﹤0.01%	339
2022 Q3	$57K	Hold	597	–	–	﹤0.01%	321
2022 Q2	$55K	Hold	597	–	–	﹤0.01%	327
2022 Q1	$60K	Hold	597	–	–	﹤0.01%	323
2021 Q4	$62K	Hold	597	–	–	﹤0.01%	326
2021 Q3	$51K	Hold	597	–	–	﹤0.01%	335
2021 Q2	$50K	Hold	597	–	–	﹤0.01%	336
2021 Q1	$45K	Hold	597	–	–	﹤0.01%	336
2020 Q4	$41K	Hold	597	–	–	﹤0.01%	335
2020 Q3	$35K	Hold	597	–	–	﹤0.01%	338
2020 Q2	$39K	Hold	597	–	–	﹤0.01%	317
2020 Q1	$35K	Hold	597	–	–	﹤0.01%	316
2019 Q4	$44K	Hold	597	–	–	﹤0.01%	331
2019 Q3	$38K	Hold	597	–	–	﹤0.01%	337
2019 Q2	$33K	Hold	597	–	–	﹤0.01%	359
2019 Q1	$32K	Hold	597	–	–	﹤0.01%	362
2018 Q4	$39K	Buy	597 +130	+28%	+$9.7K	﹤0.01%	328
2018 Q3	$37K	Hold	467	–	–	﹤0.01%	345
2018 Q2	$30K	Hold	467	–	–	﹤0.01%	364
2018 Q1	$29K	Hold	467	–	–	﹤0.01%	365
2017 Q4	$34K	Buy	+467	New	+$34K	﹤0.01%	343
2017 Q1	–	Sell	-535	Closed	-$42K	–	404
2016 Q4	$42K	Buy	+535	New	+$43.3K	﹤0.01%	298

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EARNEST Partners's CVS Position: Q4 2023 in Review

EARNEST Partners sold out of CVS Health (CVS) in Q4 2023, closing a stake of 597 shares — an estimated $41.7K sold.

EARNEST Partners first reported a position in CVS in Q4 2016 and held it in 25 quarters. The position peaked at $62K in Q4 2021. 2,263 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

EARNEST Partners reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 597 CVS Health shares in Q4 2023, an estimated $41.7K.
EARNEST Partners first reported a position in CVS Health in Q4 2016 and held it in 25 quarters.
EARNEST Partners's CVS Health position peaked at $62K in Q4 2021.
2,263 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.